McGovern Medical School at The University of Texas Health Science Center, Houston.
Retina Consultants of Houston, Houston, Texas.
JAMA Ophthalmol. 2018 May 1;136(5):482-488. doi: 10.1001/jamaophthalmol.2018.0561.
Intraoperative adequacy check of biopsy samples can lead to a higher biopsy yield rate, and subsequent genomic analysis can provide patients with valuable prognostic information.
To examine the yield rates for transscleral and transvitreal fine-needle aspiration biopsies of small uveal melanoma less than 3.6 mm in apical height and to discuss techniques that would maximize yield rates and minimize complications.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective, consecutive observational case series was conducted from January 29, 2013, to May 23, 2017, at Retina Consultants of Houston and Houston Methodist Hospital among 44 patients with uveal melanoma of the ciliary body or choroid.
Fine-needle aspiration biopsy and intraoperative histopathologic analysis prior to iodine 125 brachytherapy.
Tumor locations and dimensions were identified by histopathologic analysis and B-scan ultrasonography. Either transscleral or transvitreal biopsy was performed for tumors anterior to the equator and posterior to the equator, respectively. Biopsy specimens were checked for adequacy intraoperatively. Specimens were examined using hematoxylin-eosin, double immunostain with human melanoma black 45 and Ki67, and gene expression profile.
A total of 44 patients were included in the study, with a mean (SD) age of 63.3 (12.7) years (21 men [47.7%]; 23 women [52.3%]). Median tumor height was 2.7 mm (interquartile range, 2.3- 2.9 mm). Forty of 44 biopsy samples (90.9%; 95% CI, 82.4%-99.4%) yielded adequate cells for gene expression profile analysis. Transscleral and transvitreal yield rates were 11 of 11 (100%) and 29 of 33 (87.9%), respectively. Most localized vitreous hemorrhages were resolved by 3 months. There was a moderate association between localized vitreous hemorrhage and transvitreal biopsy method, for which the phi value was -0.526 (95% CI, -0.712 to -0.157; P < .001).
These findings suggest intraoperative adequacy evaluation of fine-needle aspiration biopsy specimens leads to high yield and is more informative for patients.
术中活检样本的充分性检查可提高活检的阳性率,随后的基因组分析可为患者提供有价值的预后信息。
探讨经巩膜和经玻璃体细针抽吸活检在小于 3.6mm 顶高的小脉络膜黑色素瘤中的应用,讨论提高活检阳性率、降低并发症发生率的方法。
设计、设置和参与者:这是一项于 2013 年 1 月 29 日至 2017 年 5 月 23 日在休斯顿视网膜顾问和休斯顿卫理公会医院进行的回顾性、连续观察性病例系列研究,共纳入 44 例睫状体或脉络膜脉络膜黑色素瘤患者。
碘 125 近距离放射治疗前进行细针抽吸活检和术中组织病理学分析。
通过组织病理学分析和 B 型超声扫描确定肿瘤位置和大小。对于赤道前和赤道后的肿瘤,分别进行经巩膜或经玻璃体活检。术中检查活检标本的充分性。使用苏木精-伊红、人黑色素瘤黑 45 和 Ki67 的双重免疫染色和基因表达谱对标本进行检查。
共纳入 44 例患者,平均(SD)年龄为 63.3(12.7)岁(21 例男性[47.7%];23 例女性[52.3%])。中位肿瘤高度为 2.7mm(四分位间距,2.3-2.9mm)。44 例活检样本中有 40 例(90.9%;95%CI,82.4%-99.4%)可用于基因表达谱分析。经巩膜和经玻璃体活检的阳性率分别为 11 例(100%)和 29 例(87.9%)。大多数局限性玻璃体积血在 3 个月内得到解决。局限性玻璃体积血与经玻璃体活检方法之间存在中度相关性,phi 值为-0.526(95%CI,-0.712 至-0.157;P<.001)。
这些发现表明,术中对细针抽吸活检标本的充分性评估可提高活检阳性率,并为患者提供更有价值的信息。